[Type IV of hypersensitivity and its subtypes]

Area of Science:

• Immunology
• Dermatology
• Allergology

Background:

• Type IV hypersensitivity reactions traditionally linked to Th1 cells and contact allergy.
• Recent research reveals more complex mechanisms involving various T-cell subsets and cytokines.
• Clinical manifestations of Type IV reactions vary significantly, suggesting underlying mechanistic differences.

Purpose of the Study:

• To re-evaluate and re-classify Type IV hypersensitivity reactions based on updated mechanistic insights.
• To correlate specific subtypes of Type IV reactions with distinct clinical presentations and etiological factors.
• To provide a framework for improved differential diagnosis and targeted treatment of allergic diseases.

Main Methods:

• Analysis of T-cell subsets (CD4+, CD8+) and their secreted cytokines (e.g., IFN-gamma, IL-4, IL-8, GM-CSF).
• Immunohistochemical and functional characterization of reactive T-cells in various skin conditions.
• Re-classification of Type IV reactions into four subtypes (IVa, IVb, IVc, IVd) based on dominant T-cell and cytokine profiles.

Main Results:

• Type IV reactions are triggered by specific T-cell activation (CD4+ and CD8+) and cytokine profiles.
• Four subtypes identified: IVa (Th1/monocyte), IVb (Th2/eosinophil), IVc (CD8+ cytotoxic), and IVd (CD4+/CD8+/neutrophil).
• Specific subtypes are associated with distinct clinical patterns: IVa/IVc in contact dermatitis, IVb in asthma/allergic rhinitis, IVc in Stevens-Johnson Syndrome, and IVd in pustular eruptions.

Conclusions:

• The re-classification of Type IV hypersensitivity reactions into four subtypes provides a more nuanced understanding of their pathogenesis.
• Distinct T-cell and cytokine profiles underlie the diverse clinical manifestations of Type IV allergic reactions.
• This mechanistic understanding is crucial for accurate differential diagnosis and effective therapeutic strategies in allergic diseases.